Sticky Post
2
SocialDiabetes, a leader in the digital transformation of healthcare, today announces the launch of “Listen.Doctor“, an advanced AI-powered tool that transforms medical consultations into actionable knowledge. Listen.Doctor, with the slogan “Transform your conversations into knowledge”, uses two of the most advanced language models to listen, transcribe, summarise and extract the key points of medical conversations...
People living with diabetes, more than 6 million in Spain, must learn and develop self-management skills in order to adequately control their glucose levels and avoid complications and general deterioration of their health. This lifestyle change is not only related to their pharmacological treatment and monitoring, they also have to incorporate healthy nutrition and smart...
SocialDiabetes and Dexcom Partner to Help People with Diabetes Improve Management and Control of the Disease Madrid, September 26, 2023 – Dexcom, a company specializing in continuous glucose monitoring (CGM) systems for people with diabetes, and SocialDiabetes, a reference platform certified as a medical device internationally for diabetes management, have joined forces to help people...
Integrated Diabetes Services LLC and SocialDiabetes join forces to create a new virtual care offering for Diabetic population Spanish-speakers in America.  It’s a holistic, culturally-responsive approach to health that’s a widely demanded need for an often under-treated community.
We have completed the integration with Nightscout. This allows us to read from any continuous monitor you use with your Nightscout
The collaboration between SocialDiabetes and the University of Girona aims to accelerate the adoption of AI by patients and professionals.
Diabetes (a chronic disease that affects more than 6 million people in Spain) conditions people’s lives and their daily habits. Patients have to continuously check their blood sugar, eat healthily, exercise regularly, and follow the pharmacological treatment, which in the most severe cases involves injecting insulin daily. Improving the quality of life of these patients...
Diabetic retinopathy (DR) remains one of the leading causes of vision loss in the working-age population, affecting more than a third of all people living with diabetes (IDF 2020). With this panorama of the health and economic impact of the DR, having tools and technology that already contributes to the prevention and timely detection of...